OraPharma returns US rights to Sinclair's Decapinol
This article was originally published in Scrip
Executive Summary
More than two years after the planned launch of the prescription mouth rinse Decapinol (delmopinol) in the US, Sinclair Pharma has regained rights to its product from the Johnson & Johnson subsidiary OraPharma. Although an exclusive US licensing deal was signed in June 2006, when Sinclair said US sales would begin within 12 months, Decapinol is still not available in the US.